Obesity promotes the accumulation of myeloperoxidase (MPO)-releasing myeloid cells within PVAT, and MPO levels correlate positively with body weight and endothelial dysfunction in both obese patients and animal models. This evidence concerns the gene MPO and obesity due to melanocortin 4 receptor deficiency.